-
1.发明授权Method of verifying integrity of data written by a mainframe to a virtual tape and providing feedback of errors 有权验证由主机写入虚拟磁带的数据的完整性并提供错误反馈的方法公开(公告)号：US08775756B1
公开(公告)日：2014-07-08
申请号：US13433477
申请日：2012-03-29
IPC分类号： G06F1/00 , G06F13/00 , G06F13/28 , G06F7/00 , G06F17/00 , G06F3/06 , G06F11/07 , G06F12/00 , G06F11/14 , G06F17/30
CPC分类号： G06F3/06 , G06F3/0619 , G06F3/065 , G06F3/0664 , G06F11/0766 , G06F11/1446 , G06F12/00 , G06F17/30088 , G06F17/30377 , G06F2201/82 , G06F2201/84 , G06F2212/1032 , G06F2212/151 , G06F2212/165
摘要： A virtual tape emulator (VTE) that performs data integrity read back verification at host sync points. The VTE first flushes data that it may have buffered to a backend storage subsystem such as a disk array. The VTE then reads all data that was written to the backend storage array between a prior sync point and the current sync point. During this feedback verification, integrity checks can be performed. An error detected during read back verification is returned to the host operation that triggered the sync operation.
摘要翻译： 在主机同步点执行数据完整性的虚拟磁带仿真器（VTE）读回验证。 VTE首先将数据缓冲到后端存储子系统（如磁盘阵列）中。 VTE然后读取在先前同步点和当前同步点之间写入后端存储阵列的所有数据。 在此反馈验证期间，可以执行完整性检查。 在回读验证期间检测到的错误返回到触发同步操作的主机操作。
-
2.发明授权H5 proteins, nucleic acid molecules and vectors encoding for those, and their medicinal use 有权H5蛋白，核酸分子和编码它们的载体及其药物用途公开(公告)号：US08592558B2
公开(公告)日：2013-11-26
申请号：US13476405
申请日：2012-05-21
IPC分类号： C07K1/00 , A61K39/00 , A61K39/145
CPC分类号： A61K39/145 , A61K39/00 , A61K39/12 , A61K2039/53 , A61K2039/55555 , A61K2039/55566 , C07K14/005 , C12N2760/16122 , C12N2760/16134
摘要： The present invention relates to novel hemagglutinin H5 proteins, nucleic acids and vectors encoding for those as well as vaccines comprising any of such H5 proteins, nucleic acids or vectors encoding for those H5 proteins. Moreover, the present invention also relates to the medicinal use of any of such compositions in humans and animals.
摘要翻译： 本发明涉及新的血凝素H5蛋白，核酸和编码这些蛋白的载体以及包含任何这样的H5蛋白，核酸或编码这些H5蛋白的载体的疫苗。 此外，本发明还涉及任何这样的组合物在人和动物中的药物用途。
-
公开(公告)号：US5419907A
公开(公告)日：1995-05-30
申请号：US974251
申请日：1992-11-10
申请人： Prem S. Paul , Eric M. Vaughn , Patrick G. Halbur
发明人： Prem S. Paul , Eric M. Vaughn , Patrick G. Halbur
IPC分类号： A61K39/00 , C07K14/17 , C12N7/00 , A61K39/215 , A61K39/225 , C12N7/06 , C12N7/08
CPC分类号： C07K14/005 , C12N7/00 , A61K39/00 , C12N2770/20021 , C12N2770/20022 , Y10S424/815
摘要： The present invention provides a biologically pure culture of a novel pathogenic porcine respiratory coronavirus (PRCV) and a vaccine derived therefrom effective against PRCV infection and transmissible gastroenteritis virus (TGEV) infection.
摘要翻译： 本发明提供了一种新型病原性猪呼吸道冠状病毒（PRCV）的生物学纯培养物，以及有效抗PRCV感染和传染性胃肠炎病毒（TGEV）感染的疫苗。
-
4.发明申请MULTIVALENT VACCINE AGAINST PORCINE TESCHOVIRUS AND OTHER DISEASE CAUSING ORGANISMS IN SWINE 审中-公开多种疫苗对斑马鱼和其他疾病引起的毒素公开(公告)号：US20110150770A1
公开(公告)日：2011-06-23
申请号：US12964073
申请日：2010-12-09
申请人： Elida BAUTISTA , Dianna M. Murphy JORDAN , Axel NEUBAUER , Abby Rae PATTERSON , Michael B. Roof , Eric M. VAUGHN , Joseph G. Victoria
发明人： Elida BAUTISTA , Dianna M. Murphy JORDAN , Axel NEUBAUER , Abby Rae PATTERSON , Michael B. Roof , Eric M. VAUGHN , Joseph G. Victoria
IPC分类号： A61K39/295 , A61K39/39 , A61K39/125 , A61K49/00 , A61P31/04 , A61P31/14 , B65D85/00
CPC分类号： A61K39/125 , A61K39/12 , A61K2039/5252 , A61K2039/543 , A61K2039/552 , A61K2039/55566 , A61K2039/70 , C12N7/00 , C12N2750/10034 , C12N2770/10034 , C12N2770/32034
摘要： An immunogenic composition or vaccine, and method of treatment are provided by the present invention. The immunogenic composition is useful for treating, preventing, and lessening the severity of clinical symptoms associated with disease-causing organisms in swine, utilizing one or more Porcine Teschovirus antigen(s) along with an antigen of the other disease-causing organism in swine and a pharmaceutically acceptable carrier.
摘要翻译： 免疫原性组合物或疫苗以及治疗方法由本发明提供。 免疫原性组合物可用于治疗，预防和减轻与猪中的致病生物体相关的临床症状的严重性，利用一种或多种猪Teschovirus抗原以及猪中其他致病生物的抗原，以及 药学上可接受的载体。
-
公开(公告)号：US07722878B2
公开(公告)日：2010-05-25
申请号：US11154617
申请日：2005-06-16
申请人： Eric M. Vaughn , Richard Stammer
发明人： Eric M. Vaughn , Richard Stammer
IPC分类号： A61K39/12
CPC分类号： C07K14/005 , A61K2039/53 , C12N2770/10022 , C12N2770/10034 , C12N2770/10071
摘要： Vaccines effective against PRRSV include at least one portion of PRRSV ORF1. Such vaccines, upon administration, provoke an immune response in PRRSV-susceptible animals. Moreover, compositions in accordance with the present invention provide immune response up to and including protective immunity against PRRSV as well as reduce the severity of PRRSV and/or incidence of PRRSV. Selected portions of ORF1 can be used singularly, in combination with one another, in combination with other PRRSV ORFs, and in combination with other PRRSV vaccines.
摘要翻译： 针对PRRSV有效的疫苗包括PRRSV ORF1的至少一部分。 这种疫苗在给药后会引起PRRSV敏感性动物的免疫反应。 此外，根据本发明的组合物提供直到并包括针对PRRSV的保护性免疫的免疫应答以及降低PRRSV的严重性和/或PRRSV的发生率。 ORF1的选定部分可以单独使用，相互结合使用，与其他PRRSV ORF组合使用，并与其他PRRSV疫苗组合使用。
-
公开(公告)号：US20080038293A1
公开(公告)日：2008-02-14
申请号：US11154617
申请日：2005-06-16
申请人： Eric M. Vaughn , Richard Stammer
发明人： Eric M. Vaughn , Richard Stammer
CPC分类号： C07K14/005 , A61K2039/53 , C12N2770/10022 , C12N2770/10034 , C12N2770/10071
摘要： Vaccines effective against PRRSV include at least one portion of PRRSV ORF1. Such vaccines, upon administration, provoke an immune response in PRRSV-susceptible animals. Moreover, compositions in accordance with the present invention provide immune response up to and including protective immunity against PRRSV as well as reduce the severity of PRRSV and/or incidence of PRRSV. Selected portions of ORF1 can be used singularly, in combination with one another, in combination with other PRRSV ORFs, and in combination with other PRRSV vaccines.
摘要翻译： 针对PRRSV有效的疫苗包括PRRSV ORF1的至少一部分。 这种疫苗在给药后会引起PRRSV敏感性动物的免疫反应。 此外，根据本发明的组合物提供直到并包括针对PRRSV的保护性免疫的免疫应答以及降低PRRSV的严重性和/或PRRSV的发生率。 ORF1的选定部分可以单独使用，相互结合使用，与其他PRRSV ORF组合使用，并与其他PRRSV疫苗组合使用。
-
-
-
-
-
搜索结果
6 条记录 (耗时 0.019 秒)
